Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome (AXSM) Surges on Potential Approval for AXS-05 Soon
12:02pm, Wednesday, 20'th Apr 2022
The FDA provides post-marketing requirements/commitments related to Axsome's (AXSM) under-review NDA for its lead pipeline candidate, AXS-05, for treating MDD. Investors anticipate an approval shortly
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
12:05pm, Tuesday, 19'th Apr 2022
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA. The post Why Is Axsome Therapeutics (AXSM) Stock Up Today?
Why Axsome Therapeutics Is Jumping Higher on Tuesday
10:43am, Tuesday, 19'th Apr 2022
A long-awaited FDA decision regarding AXS-05 finally has a timeline.
Axsome Therapeutics Stock Is Surging: Here's Why
09:45am, Tuesday, 19'th Apr 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed by the U.S. Food and Dru
Axsome: A Growth Transition
12:04pm, Wednesday, 13'th Apr 2022
The recent Sunosi acquisition delivers pipeline synergy as well as making Axsome revenue positive. AXS07 is poised to gain FDA approval to better serve patients afflicted by migraines.
Axsome: A Speculative Buy, Undervalued Biotech With A Short-Term Catalyst
06:48am, Sunday, 03'rd Apr 2022
We are initiating coverage of Axsome Therapeutics with a BUY rating, TP of 120 USD.
3 CEOs to Invest In
09:00pm, Friday, 01'st Apr 2022
Looking for a healthcare stock with strong leadership? Our roundtable likes Immunocore, Axsome Therapeutics, and GlaxoSmithKline.
3 Top Health Care Stocks To Watch Today
04:30pm, Friday, 01'st Apr 2022
Could these health care stocks be healthy additions to your portfolio?
Axsome (AXSM) Up 27.3% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 31'st Mar 2022
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Why Axsome Therapeutics Crushed the Market Again Today
06:19pm, Tuesday, 29'th Mar 2022
Two analysts boost their price targets on the company's stock.
Why Axsome Therapeutics Stock Climbed 11.1% on Monday
05:36pm, Monday, 28'th Mar 2022
The company announced that it was buying a therapy from Jazz Pharmaceuticals.
Why Axsome Therapeutics Stock Is Trading Higher
09:12am, Monday, 28'th Mar 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ). Jazz will receive a total upfront
Axsome: You Won't Find These Prices Again
09:42am, Tuesday, 22'nd Mar 2022
AXSM has a pivotal few months up ahead.
Axsome: A Biotech With Potential Approval Of Several Drugs In Coming Years
01:45am, Saturday, 19'th Mar 2022
Potential to still achieve FDA approval of AXS-05 for patients with major depressive disorder; a response for CMC issues were submitted to the FDA and further review is ongoing.
3 Biotech Stocks That Can Make You Richer in March (and Beyond)
07:04am, Sunday, 06'th Mar 2022
These biotechs have promising near-term and long-term prospects.
